Overview

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

Status:
COMPLETED
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
A Multi-center, Randomized, Double-blind, Parallel, Phase Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients with Dyslipidemia
Phase:
PHASE3
Details
Lead Sponsor:
JW Pharmaceutical